Related references
Note: Only part of the references are listed.The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
DnA Repair and Cytokines: TGF-β, IL-6, and Thrombopoietin as Different Biomarkers of Radioresistance
Lucia Centurione et al.
FRONTIERS IN ONCOLOGY (2016)
PKR inhibits the DNA damage response, and is associated with poor survival in AML and accelerated leukemia in NHD13 mice
Xiaodong Cheng et al.
BLOOD (2015)
Urokinase receptor and CXCR4 are regulated by common microRNAs in leukaemia cells
Daniela Alfano et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Acute Myelogenous Leukemia and its Microenvironment: A Molecular Conversation
Gabriel Ghiaur et al.
SEMINARS IN HEMATOLOGY (2015)
Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells
Sawa Ito et al.
STEM CELL RESEARCH (2015)
The cytokine-mediated crosstalk between primary human acute myeloid cells and mesenchymal stem cells alters the local cytokine network and the global gene expression profile of the mesenchymal cells
Hakon Reikvam et al.
STEM CELL RESEARCH (2015)
Effects of cytarabine on activation of human T cells - cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acid
Elisabeth Ersvaer et al.
BMC PHARMACOLOGY & TOXICOLOGY (2015)
CME Information: Acute myeloid leukemia: 2014 update on risk-stratification and management
Elihu H. Estey
AMERICAN JOURNAL OF HEMATOLOGY (2014)
In Search of Antiaging Modalities: Evaluation of mTOR- and ROS/ DNA Damage-Signaling by Cytometry
Zbigniew Darzynkiewicz et al.
CYTOMETRY PART A (2014)
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
Xin Yao et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Concise Review: The Surface Markers and Identity of Human Mesenchymal Stem Cells
Feng-Juan Lv et al.
STEM CELLS (2014)
Functional Adaptation of Presynaptic Chemokine Receptors in EAE Mouse Central Nervous System
Silvia Di Prisco et al.
SYNAPSE (2014)
A Niche-Like Culture System Allowing the Maintenance of Primary Human Acute Myeloid Leukemia-Initiating Cells: A New Tool to Decipher Their Chemoresistance and Self-Renewal Mechanisms
Emmanuel Griessinger et al.
STEM CELLS TRANSLATIONAL MEDICINE (2014)
The life and fate of mesenchymal stem cells
Elke Eggenhofer et al.
FRONTIERS IN IMMUNOLOGY (2014)
Differences in proliferative capacity of primary human acute myelogenous leukaemia cells are associated with altered gene expression profiles and can be used for subclassification of patients
H. Reikvam et al.
CELL PROLIFERATION (2013)
Myeloproliferative Neoplasia Remodels the Endosteal Bone Marrow Niche into a Self-Reinforcing Leukemic Niche
Koen Schepers et al.
CELL STEM CELL (2013)
Vascular endothelial growth factor signaling in acute myeloid leukemia
Kim R. Kampen et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Cytokine profiles in acute myeloid leukemia patients at diagnosis: Survival is inversely correlated with IL-6 and directly correlated with IL-10 levels
Beatriz Sanchez-Correa et al.
CYTOKINE (2013)
The Possible Diagnostic and Prognostic Use of Systemic Chemokine Profiles in Clinical Medicine-The Experience in Acute Myeloid Leukemia from Disease Development and Diagnosis via Conventional Chemotherapy to Allogeneic Stem Cell Transplantation
Hakon Reikvam et al.
TOXINS (2013)
The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia
Hanne Fredly et al.
CLINICAL EPIGENETICS (2013)
The angioregulatory cytokine network in human acute myeloid leukemia - from leukemogenesis via remission induction to stem cell transplantation
Hakon Reikvam et al.
EUROPEAN CYTOKINE NETWORK (2012)
Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts
Olga Blau et al.
BLOOD (2011)
p53 activation of mesenchymal stromal cells partially abrogates microenvironment-mediated resistance to FLT3 inhibition in AML through HIF-1α-mediated down-regulation of CXCL12
Kensuke Kojima et al.
BLOOD (2011)
CCR1 as a target for multiple myeloma
Sonia Vallet et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Therapeutic Advances in Acute Myeloid Leukemia
Alan Burnett et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias
I. Spinello et al.
BLOOD CANCER JOURNAL (2011)
Specific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemia
J. Skavland et al.
BLOOD CANCER JOURNAL (2011)
Targeting mTOR for the treatment of AML. New agents and new directions.
Jessica K. Altman et al.
ONCOTARGET (2011)
Impact of CXCR4 inhibition on FLT3-ITD-positive human AML blasts
Angela Jacobi et al.
EXPERIMENTAL HEMATOLOGY (2010)
Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia
Sophie Park et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
Bruno Nervi et al.
BLOOD (2009)
The leukemic stem cell niche: current concepts and therapeutic opportunities
Steven W. Lane et al.
BLOOD (2009)
Growth inhibition of AML cells with specific chromosome abnormalities by monoclonal antibodies to receptors for vascular endothelial growth factor
Norikazu Imai et al.
LEUKEMIA RESEARCH (2009)
Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome
S. Boehrer et al.
ONCOGENE (2009)
The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation
S. Tavor et al.
LEUKEMIA (2008)
Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-Cell responses against viral or tumor-associated antigens
Fabio Morandi et al.
STEM CELLS (2008)
Mesenchymal stem cells in health and disease
Antonio Uccelli et al.
NATURE REVIEWS IMMUNOLOGY (2008)
The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells
J. Golay et al.
LEUKEMIA (2007)
The CXCR4 chemokine receptor in acute and chronic leukaemia:: a marrow homing receptor and potential therapeutic target
Jan A. Burger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias
Brunangelo Falini et al.
HAEMATOLOGICA (2007)
Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells
Oystein Bruserud et al.
HAEMATOLOGICA (2007)
Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells
Yoko Tabe et al.
CANCER RESEARCH (2007)
Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents
Toshiki Tanaka et al.
CYTOMETRY PART A (2007)
Stress-induced in vitro apoptosis of native human acute myelogenous leukemia (AML) cells shows a wide variation between patients and is associated with low BCL-2:Bax ratio and low levels of heat shock protein 70 and 90
Anita Ryningen et al.
LEUKEMIA RESEARCH (2006)
Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model
Eline Menu et al.
CLINICAL & EXPERIMENTAL METASTASIS (2006)
Activation of FGFR1β signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells
M. A. Karajannis et al.
LEUKEMIA (2006)
Phosphorylation of histone H2AX at M phase in human cells without DNA damage response
Y Ichijima et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
MIP-1α utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells
Y Oba et al.
EXPERIMENTAL HEMATOLOGY (2005)
Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist
FL de Mendonça et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes
A Aguayo et al.
CANCER (2002)
Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins
M Konopleva et al.
LEUKEMIA (2002)
Pluripotency of mesenchymal stem cells derived from adult marrow
YH Jiang et al.
NATURE (2002)
Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia
B Brunner et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2002)
Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5)
SM Garrido et al.
EXPERIMENTAL HEMATOLOGY (2001)
New strategies in the treatment of acute myelogenous leukemia (AML): In vitro culture of AML cells - The present use in experimental studies and the possible importance for future therapeutic approaches
O Bruserud et al.
STEM CELLS (2001)
A small molecule antagonist of chemokine receptors CCR1 and CCR3 - Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry
I Sabroe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Mesenchymal stem cells: Biology and potential clinical uses
RJ Deans et al.
EXPERIMENTAL HEMATOLOGY (2000)
Share Paper
